Barts Cancer Centre | Cancer types | Blood and lymph gland cancer

Professor of Experimental Cancer Medicine and Dire
020 7882 6052
020 7796 3979
john.gribben@bartsandthelondon.nhs.uk
Professor John Gribben graduated from the University of Glasgow in 1980. He subsequently trained in Haematology at University College London and in Medical Oncology at the Dana-Farber Cancer Institute, Harvard Medical School, where he remained on the faculty for 17 years before returning to the UK. He is both an accredited physician and a medical oncologist. He specialises in haematolgical cancers including lymphomas, leukaemias and bone marrow transplantation.
Author of more than 300 articles and chapters in peer-reviewed publications, he has a global reputation for his work in researching new drugs and forms of cancer treatment. He has grant funding from The National Cancer Institute and Cancer Research UK for pioneering studies in leukaemia and lymphoma. He has sat on or chaired numerous international executive committees dedicated to investigating new approaches to cancer care, and several of the editorial boards for professional publications which are focused on cancer. He has recently been appointed an Editor of Blood. He has lectured across the world on new therapies for cancer treatment.
For full details of Professor Gribben's biography, please visit the School of Medicine and Dentistry's website at www.cancer.qmul.ac.uk/staff/gribben.html
Lymphoma, leukaemia and stem cell transplant
Chronic lymphocytic leukaemia, allogeneic bone marrow transplantation; other lymphoid malignancies